Labelling as experimental or for research only does not make it legal to sell, supply, possess or use
ANIMAL SAFETY SUMMARY: Adult dogs receiving enrofloxacin orally at a daily dosage rate 52 mg/kg for 13 weeks had only isolated incidences of vomition and inappetence
PubChem Reference: View compound profile on NIH PubChem Key Characteristics MOLECULAR PROFILE Formula: C 14 H 22 N 4 O 9 Weight: 390.34 g/mol CAS: 307297-39-8 Structure: Ala-Glu-Asp-Gly PHYSICAL PROPERTIES Form: White lyophilized powder Solubility: Readily dissolves in water Origin: Synthetic version of epithalamin Storage: Keep refrigerated 3646 F (28 C) Related products BPC-157 $40.00 $65.00Price range: $40.00 through $65.00 NAD+ $40.00 $125.00Price range: $40.00 through $125.00
If youre interested, Synedica has a product that has the two compounds combined, making the dual-peptide formulation process easier
At REVIV, we prioritize your safety
The molecule was developed by Frank Ng's group at Monash University and Metabolic Pharmaceuticals in Australia during the 1990s and 2000s as a potential anti-obesity drug intended to isolate the lipolytic region of hGH without activating the growth hormone receptor or raising IGF-1.nnIn published preclinical work, the fragment has been shown to stimulate lipolysis, suppress lipogenesis, and modulate the beta-3 adrenergic receptor pathway in adipose tissue rather than acting through the classical hGH receptor
